1. |
陈洁, 李岩, 王晶, 等.耐甲氧西林金黄色葡萄球菌SCCmec基因分型及耐药谱分析.中华医院感染学杂志, 2012, 22(5):894-897.
|
2. |
王爽, 宋志香.耐甲氧西林金黄色葡萄球菌感染的临床特征、耐药性及治疗研究进展.实用医院临床杂志, 2009, 6(4):137-139.
|
3. |
Gould IM. Clinical activity of anti-Gram-positive agents against methicillin-resistant staphyl-lococcus aereus. Antimicrob Agents Chemother, 2011, 66:17-21.
|
4. |
Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. Antimicrob Agents Chemother, 1996, 37:209-222.
|
5. |
中华医学会, 中华医院管理学会药事管理专业委员会, 中国药学会医院药学专业委员会.抗菌药物临床应用指导原则.中华医学杂志, 2004, 84(23):1857-1862.
|
6. |
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available at:www.cochrane-handbook.org.
|
7. |
Auwera P, Aoun M, Meunier F. Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts. Antimicrob Agents Chemother, 1991, 35:451-457.
|
8. |
Smith SR, Cheesbrough J, Spearing R, et al. Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with hickman catheters. Antimicrob Agents Chemother, 1989, 33:1193-1197.
|
9. |
Liu CY, Lee WS, Fung CP, et al. Comparative study of teicoplanin vs vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia. Clin Drug Investig, 1996, 12:80-87.
|
10. |
Kureishi A, Jewesson PJ, Rubinger M, et al. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin:effect on cyclosporin associated nephrotoxicity. Antimicrob Agents Chemother, 1991, 35:2246-2252.
|
11. |
Nucci M, Biasoli I, Braggio S, et al. Ceftazidime plus amikacin plusteicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients. Oncol Rep, 1998, 5:1205-1209.
|
12. |
Figuera A, Tomas JF, Hernandez L, et al. Fernandez-Ranada Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes. Rev Clin Esp, 1996, 196:515-522.
|
13. |
Gilbert DN, Wood CA, Kimbrough RC, et al. Failure of treatment with teicoplanin at 6 Milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. Anti-microb Agents Chemother, 1991, 35:79-87.
|
14. |
Vazquez L, Encinas MP, Morin LS, et al. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. Haematologica, 1999, 84:231-236.
|
15. |
唐咏梅.替考拉宁与万古霉素对革兰阳性菌感染的疗效及安全性分析.中国药业, 2013, 22(15):15-16.
|
16. |
吕芳芳, 周志慧, 俞云松, 等.替考拉宁与万古霉素随机对照多中心临床研究.中国临床药理学杂志, 2002, 78(4):343-246.
|
17. |
董裸, 陈小东.替考拉宁与万古霉素治疗MASA下呼吸道感染的疗效与安全性评价.中华医院感染学杂志, 2010, 20(5):711-712.
|
18. |
彭浩, 贺全勇, 罗成群, 等.替考拉宁与万古霉素治疗重度烧伤合并MASA感染的临床观察.中华医院感染学杂志, 2010, 20(11):1594-1595.
|
19. |
祖育娜, 许爱国.替考拉宁与万古霉素治疗重症革兰阳性菌感染的疗效和安全性.中华医院感染学杂志, 2010, 20(4):552-554.
|
20. |
冯靖雄.替考拉宁与万古霉素随机对照治疗重症G+球菌感染的疗效和安全性.北方药学, 2012, 9(8):73-74.
|
21. |
赵卫峰, 凌春华, 张险峰, 等.替考拉宁与万古霉素随机对照治疗重症G+球菌感染的临床研究.江苏医药, 2003, 29(12):913-915.
|
22. |
张天托, 黄树灿, 周凤丽, 等.替考拉宁治疗G+菌感染的疗效和安全性.中国新药杂志, 2003, 12(12):1041-1043.
|
23. |
孙晓霞, 方巍, 孙运波.万古霉素和替考拉宁治疗ICU耐甲氧西林金黄色葡萄球菌感染的评价.齐鲁医学杂志, 2009, 24(6):533-537.
|
24. |
朱惠莉, 龚瑾, 符礼刚, 等.替考拉宁与万古霉素治疗老年人耐甲氧西林金葡菌肺部感染的评价.中国临床医学, 2003, 10(2):183-185.
|
25. |
谢续标, 叶明佶, 彭龙开, 等.国产替考拉宁与进口万古霉素治疗肾移植术后革兰阳性球菌肺部感染的评价.中华医院感染学杂志, 2010, 20(15):2296-2298.
|
26. |
胡述平, 薛南平, 晏怡.鞘内注射替考拉宁治疗革兰阳性球菌颅内感染.重庆医学, 2009, 38(19):2486-2487.
|
27. |
杨世杰.药理学.第2版.北京:人民卫生出版社, 2010:385-386.
|
28. |
Kullar R, Davis SL, Levine DP, et al. Impact of vancomycin exposure on outcomes in patientswith methicillin-resistant Staphylo-coccus aureus bacteremia:support for consensus guidelines suggested targets. Clin Infect Dis, 2011, 52(8):975-981.
|
29. |
张献全, 张安, 王鹏飞, 等.替考拉宁治疗ICU耐甲氧西林金黄色葡萄球菌感染的疗效观察.中华医院感染学杂志, 2009, 19(22):3099-3101.
|
30. |
Sancar AA, Yegenoglu S, Vries R, et al. Vancomycin vs teicoplanin in the treatment of gram-positive infections:a armacoeconomic analysis in a Turkish Unive rsity Hospitial. Harm World Sci, 2008, 30:916-923.
|
31. |
张之萌.替考拉宁及万古霉素疗效与安全性比较.国外医药抗生素分册, 1997, 18(5):381-389.
|
32. |
富振英. Meta-analysis研究资料的统计分析方法.药物流行病学杂志, 1994, 3:220-222.
|